Sight Sciences, Inc. (SGHT) is a Medical - Devices company in the Healthcare sector, currently trading at $3.82. It has a SharesGrow Score of 48/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
Analyst consensus target is SGHT = $10 (+153.1% upside).
Valuation: SGHT trades at a trailing Price-to-Earnings (P/E) of -4.7 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.28.
Financials: revenue is $77M, +3%/yr average growth. Net income is $38M (loss), growing at +22.8%/yr. Net profit margin is -49.7% (negative). Gross margin is 86.2% (+3.5 pp trend).
Balance sheet: total debt is $41M against $64M equity (Debt-to-Equity (D/E) ratio 0.64, moderate). Current ratio is 10.22 (strong liquidity). Debt-to-assets is 35.4%. Total assets: $115M.
Analyst outlook: 4 / 9 analysts rate SGHT as buy (44%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 73/100 (Pass), Past 0/100 (Fail), Health 50/100 (Partial), Moat 50/100 (Partial), Future 52/100 (Partial), Income 10/100 (Fail).
